Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 18(2): 282-5, 2010 Apr.
Article in Chinese | MEDLINE | ID: mdl-20416152

ABSTRACT

In order to investigate the role of calcium pathway in myeloid differentiation, the expression level of genes related to calcium pathway in all-trans retinoic acid (ATRA)-induced NB4 cell differentiation was detected by cDNA microarray, some of which were further confirmed by quantitative real time RT-PCR. At the same time, the expressions of these genes in NB4-R1 cells treated with ATRA and 8-CPT-cAM P alone or in combination, and in differentiation of primary cells from ATRA-induced newly diagnosed APL patients were detected by real time RT-PCR. The results showed that during differentiation of ATRA-induced NB4 cells, the expressions of genes related to calcium concentration had changed, the expression of downstream effectors in calcium pathway was up-regulated and confirmed by real time RT-PCR assay. The expression of genes related to calcium concentration did not change significantly when NB4-R1 cells were treated by ATRA or 8-CPT-cAMP alone, but expression changes of those genes were similar to the changes in ATRA-induced NB4 cell differentiation when NB4-R1 cells were treated by ATRA combined with 8-CPT-cAMP. In addition, the expression changes of those genes in ATRA-induced primary cells of patients with APL were also similar to changes in ATRA-induced NB4 cell differentiation. It is concluded that calcium pathway may be involved in ATRA-induced differentiation in APL cell.


Subject(s)
Calcium/metabolism , Cell Differentiation/drug effects , Leukemia, Promyelocytic, Acute/metabolism , Tretinoin/pharmacology , Gene Expression Regulation, Leukemic , Humans , Leukemia, Promyelocytic, Acute/genetics , Signal Transduction , Tumor Cells, Cultured
2.
Zhonghua Xue Ye Xue Za Zhi ; 29(6): 366-9, 2008 Jun.
Article in Chinese | MEDLINE | ID: mdl-19031736

ABSTRACT

OBJECTIVE: To study the role of inhibitor of differentiation 1 (ID1) in ATRA-induced acute promyelocytic leukemia (APL) cells differentiation. METHODS: The expression of ID1 was detected by cDNA microarray, cycloheximide inhibition test, real-time RT-PCR and western blot. RESULTS: The expression of ID1 gene was up-regulated in ATRA-induced NB4 cells and APL cells from two patients and was independent on other proteins synthesis. ID1 expression level reached the peak at 2 h in NB4 cells induced by ATRA, its relative expression level was (359.4 +/- 48.7)-fold greater than control. ID1 expression level reached the peak at 2 h in bone marrow cells from APL patents treated with ATRA, and its level detected 3 times in one of the patient was (311.1 +/- 48.7) fold of control. The expression of ID1 protein was not up-regulated in ATRA resistant NB4-R2 cells after ATRA treatment. CONCLUSION: ID1 may be involved in ATRA-induced granulocytic differentiation as an ATRA-targeted gene.


Subject(s)
Inhibitor of Differentiation Protein 1/metabolism , Leukemia, Promyelocytic, Acute/drug therapy , Tretinoin/therapeutic use , Antineoplastic Agents/therapeutic use , Cell Differentiation , Humans , Inhibitor of Differentiation Protein 1/genetics , Leukemia, Promyelocytic, Acute/metabolism , Leukemia, Promyelocytic, Acute/pathology , Oligonucleotide Array Sequence Analysis
3.
Proc Natl Acad Sci U S A ; 102(21): 7653-8, 2005 May 24.
Article in English | MEDLINE | ID: mdl-15894607

ABSTRACT

Understanding the complexity and dynamics of cancer cells in response to effective therapy requires hypothesis-driven, quantitative, and high-throughput measurement of genes and proteins at both spatial and temporal levels. This study was designed to gain insights into molecular networks underlying the clinical synergy between retinoic acid (RA) and arsenic trioxide (ATO) in acute promyelocytic leukemia (APL), which results in a high-quality disease-free survival in most patients after consolidation with conventional chemotherapy. We have applied an approach integrating cDNA microarray, 2D gel electrophoresis with MS, and methods of computational biology to study the effects on APL cell line NB4 treated with RA, ATO, and the combination of the two agents and collected in a time series. Numerous features were revealed that indicated the coordinated regulation of molecular networks from various aspects of granulocytic differentiation and apoptosis at the transcriptome and proteome levels. These features include an array of transcription factors and cofactors, activation of calcium signaling, stimulation of the IFN pathway, activation of the proteasome system, degradation of the PML-RARalpha oncoprotein, restoration of the nuclear body, cell-cycle arrest, and gain of apoptotic potential. Hence, this investigation has provided not only a detailed understanding of the combined therapeutic effects of RA/ATO in APL but also a road map to approach hematopoietic malignancies at the systems level.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Arsenicals/pharmacology , Cell Differentiation/drug effects , Gene Expression Regulation, Neoplastic/drug effects , Leukemia, Promyelocytic, Acute/metabolism , Oxides/pharmacology , Tretinoin/pharmacology , Arsenic Trioxide , Cell Line, Tumor , Computational Biology/methods , Drug Synergism , Electrophoresis, Gel, Two-Dimensional , Granulocytes/cytology , Granulocytes/drug effects , Humans , Mass Spectrometry , Oligonucleotide Array Sequence Analysis , Proteomics/methods , Reverse Transcriptase Polymerase Chain Reaction , Systems Biology/methods
4.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi ; 21(5): 422-5, 2004 Oct.
Article in Chinese | MEDLINE | ID: mdl-15476161

ABSTRACT

OBJECTIVE: To get an insight into the molecular mechanisms of diseases development and targeted therapy at the transcriptome level and search for potential therapeutic targets. METHODS: The present researchers established a cDNA microarray platform and applied component plane presentation integrated self-organizing map (CPP-SOM) to the microarray data obtained from a differentiation model, all trans retinoic acid-induced differentiation in NB4 cells. RESULTS: The platform included 12630 unique clones, including 9436 known genes. By CPP-SOM, the researchers were able to not only well classify the regulated genes into functionally distinct categories but also depict transcriptional changes throughout the process of the development of diseases or drug treatment. CONCLUSION: The platform has proven to be steady and reliable, and the CPP-SOM could serve as an important and good tool for analysis of microarray data.


Subject(s)
Oligonucleotide Array Sequence Analysis/methods , Cell Line, Tumor , Humans , Reverse Transcriptase Polymerase Chain Reaction
5.
Proc Natl Acad Sci U S A ; 101(15): 5328-35, 2004 Apr 13.
Article in English | MEDLINE | ID: mdl-15044693

ABSTRACT

Both all-trans retinoic acid (ATRA) and arsenic trioxide (As(2)O(3)) have proven to be very effective in obtaining high clinical complete remission (CR) rates in acute promyelocytic leukemia (APL), but they had not been used jointly in an integrated treatment protocol for remission induction or maintenance among newly diagnosed APL patients. In this study, 61 newly diagnosed APL subjects were randomized into three treatment groups, namely by ATRA, As(2)O(3), and the combination of the two drugs. CR was determined by hematological analysis, tumor burden was examined with real-time quantitative RT-PCR of the PML-RAR alpha (promyelocytic leukemia-retinoic acid receptor alpha) fusion transcripts, and side effects were evaluated by means of clinical examinations. Mechanisms possibly involved were also investigated with cellular and molecular biology methods. Although CR rates in three groups were all high (> or =90%), the time to achieve CR differed significantly, with that of the combination group being the shortest one. Earlier recovery of platelet count was also found in this group. The disease burden as reflected by fold change of PML-RAR alpha transcripts at CR decreased more significantly in combined therapy as compared with ATRA or As(2)O(3) mono-therapy (P < 0.01). This difference persisted after consolidation (P < 0.05). Importantly, all 20 cases in the combination group remained in CR whereas 7 of 37 cases treated with mono-therapy relapsed (P < 0.05) after a follow-up of 8-30 months (median: 18 months). Synergism of ATRA and As(2)O(3) on apoptosis and degradation of PML-RAR alpha oncoprotein might provide a plausible explanation for superior efficacy of combination therapy in clinic. In conclusion, the ATRA/As(2)O(3) combination for remission/maintenance therapy of APL brings much better results than either of the two drugs used alone in terms of the quality of CR and the status of the disease-free survival.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Arsenicals/administration & dosage , Leukemia, Promyelocytic, Acute/drug therapy , Oxides/administration & dosage , Tretinoin/administration & dosage , Adolescent , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Arsenic Trioxide , Arsenicals/adverse effects , Female , Humans , In Situ Nick-End Labeling , Leukemia, Promyelocytic, Acute/blood , Male , Middle Aged , Neoplasm Proteins/biosynthesis , Oncogene Proteins, Fusion/biosynthesis , Oxides/adverse effects , Prospective Studies , Remission Induction , Reverse Transcriptase Polymerase Chain Reaction , Treatment Outcome , Tretinoin/adverse effects , Tumor Cells, Cultured
6.
Shanghai Kou Qiang Yi Xue ; 12(5): 344-8, 2003 Oct.
Article in Chinese | MEDLINE | ID: mdl-14966608

ABSTRACT

OBJECTIVE: To study the difference in gene expression between oral squamous cell carcinoma tissue and their surrounding normal tissue by microarray so as to investigate the preliminary mechanism of pathogenesis of oral cancer. METHODS: The tissues from 5 patients with oral squamous cell carcinoma tissue and their surrounding normal tissue from the same patients were analyzed by cDNA microarray technology(including 4124 genes). Total RNAs were isolated from two tissues, and then were reversely transcribed to cDNAs with the incorporations of fluorescent dUTP,for preparing the hybridization probes. The mixed probes were then hybridized to the cDNA microarray. After high-stringent washing, the cDNA microarray was scanned for the fluorescent signals and showed the differences between the two tissues. Bioinformatical analysis of those genes had been performed. RESULTS: Among the 4124 target genes, there were 37(0.89%)genes whose expression levels differed between the carcinoma and their surrounding normal tissues in all 5 cases. Bioinformatical analysis of those genes suggested that they may be related to the multistep process of carcinogenesis. CONCLUSION: cDNA microarray technique can simultaneously screen the different expressions of genes from 2 different kinds of tissue. Further analysis of the obtained genes will help to understand the molecular mechanism of malignant carcinoma.


Subject(s)
Gene Expression Profiling , Mouth Neoplasms/genetics , Oligonucleotide Array Sequence Analysis , Aged , Cell Division , Female , Humans , Male , Middle Aged , Mouth Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...